Notice of intent to issue a Sole Source Award for tuberculosis clinical trial management services

PresolicitationNo Set AsideActive

Key Takeaways

Contract Details

Notice ID
75D30126R73392
Opportunity Type
Presolicitation
Sub-Agency
CENTERS FOR DISEASE CONTROL AND PREVENTION
Office
CDC OFFICE OF ACQUISITION SERVICES
Posted Date
Wednesday, January 21, 2026
Response Deadline
Thursday, February 5, 2026
PSC Code
DA10
Set-Aside
No Set Aside
Place of Performance
ATLANTA, GA, 30333
Status
Active

Description

The Centers for Disease Control and Prevention Division of TB Elimination intends to award a sole source firm fixed price purchase order to OpenClinica LLC to provide a 1-year bridge contract for tuberculosis clinical trial management services to ensure the continuation of a 10-year cycle research portfolio that had lapsed due to the government wide shut down. OpenClinica LLC designed the current tracking system and has migrated all study data into their platform making it impractical to change vendors within the time needed to support the ongoing clinical trials with active enrollment of patients ongoing. The clinical trial data intake, analysis, and monitoring are essential for tracking performance of the active clinical trials and required by FDA regulation. This contract action is for

Why This Opportunity Matters

HEALTH AND HUMAN SERVICES, DEPARTMENT OF is actively seeking qualified contractors for all other professional, scientific, and technical services with a set-aside for No Set Aside businesses in ATLANTA, GA. This set-aside designation means eligible businesses face reduced competition from larger firms.

Similar Opportunities

Browse Related

Looking for more opportunities?

Browse our full directory of government contracts

View All Contracts